GENMAB AS SP.ADR/1/10DK 1 |
USA |
Gesundheit |
US3723032062 / A1WZYB |
GE91 (Frankfurt) / GMAB (NASDAQ) |
FRA:GE91, ETR:GE91, GE91:GR, NASDAQ:GMAB |
- |
https://www.genmab.com/ |
12260 Mio. EUR |
2778.21 Mio. EUR |
980.54 Mio. EUR |
1.282 EUR |
123 Mio. EUR |
2778.21 Mio. EUR |
18.6% / 1.6% |
13.35 / 12.69 |
4.7 / 2.65 / 1.21 |
35.27% / 22.8% |
- |
- / - |
- |
GENMAB ADR, GENMAB |
24.06.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|